Skip to main content
SpringerLink
Log in

Contraception and pregnancy in women affected by glycogen storage diseases

  • Original Paper
  • Published:
European Journal of Pediatrics Aims and scope Submit manuscript

Abstract

During the last decades, better understanding of specific enzymatic deficiencies has led to improved dietary management of children suffering from glycogen storage disease (GSD). Normal growth and development of infants can be achieved by a diet of regular meals supplemented by glucose and cornstarch during the night, and by monitoring glucose blood levels. This has resulted in an increase in the number of patients reaching adulthood and reproduction age. Therefore, developing a strategy for an optimal management of contraception and pregnancy is crucial for young women affected by GSD. Contraception has to be adapted to the specific metabolic requirements of women with GSD. Hormonal contraception is classically based on the combination of various synthetic progestogens and ethinyloestradiol. Ethinyloestradiol should be avoided because of a link with hepatic adenomas and is contraindicated in patients with hypertriglyceridaemia and hypercholesterolaemia. Blockade of ovulation can be achieved using high doses of progestogen alone, administered from the 5th to the 25th day of the cycle. Another scheme of hormonal contraception is based on daily administration of low doses of progestogen, which usually acts on local parameters of fertility, and can also achieve blockade of ovulation for the most recent compound proposed. Mechanical contraception using intra-uterine device is controversial for nulliparous patients. Benefits and side-effects of these different proposals are discussed. During pregnancy, the maternal nutritional state is important and a healthy maternal response to feeding and fasting is modified to ensure a constant supply of glucose for the developing fetus. Women with GSD are at risk of frequent hypoglycaemia. Only a few cases of successful pregnancies have been reported for patients with GSD. The outcomes using different approaches of dietary and obstetric management are discussed.Conclusion: in the future, multidisciplinary management is necessary to improve obstetric outcome of pregnancy in females affected with glycogen storage disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Abbreviations

GSD :

glycogen storage disease

IUD :

intra-uterine device

PID :

pelvic inflammatory disease

References

  1. Anand RS, Ganguli S, Sperling MA (1980) Effect of insulin-induced maternal hypoglycemia on glucose turnover in maternal and fetal sheep. Am J Physiol 238: E524-E532

    CAS  PubMed  Google Scholar 

  2. Apgar BS, Greenberg G (2000) Using progestins in clinical practice. Am Fam Physician 62: 1839–1846

    CAS  PubMed  Google Scholar 

  3. Bastianelli C, Farris M, Lippa A, Lucantoni V, Valente A (1998) Use of intrauterine device by nulliparous women. Prospective study and preliminary data. Minerva Ginecol 50: 231–233

    CAS  PubMed  Google Scholar 

  4. Beerthuizen RJ (1996) Pelvic inflammatory disease in intrauterine device users. Eur J Contracept Reprod Health Care 1: 237–243

    Article  CAS  PubMed  Google Scholar 

  5. Bouyer J, Rachou E, Germain E, Fernandez H (2000) Risk factors extrauterine pregnancy in women using an intrauterine device. Fertil Steril 75: 899–908

    Article  Google Scholar 

  6. Bozzetti P, Ferrari MM, Marconi AM, Ferrazzi E, Pardi G, Markowski EL, Battaglia FC (1988) The relationship of maternal and fetal glucose concentrations in the human from midgestation until term. Metabolism 37: 358–363

    Article  CAS  PubMed  Google Scholar 

  7. Collaborative Study Group on the Desogestrel-containing Progestogen-only Pill (1998) A double-blind study comparing the contraceptive efficacy, acceptability and safety of two progestogen-only pills containing desogestrel 75 micrograms/day or levonorgestrel 30 micrograms/day. Eur J Contracept Reprod Health Care 3: 169–178

    Article  Google Scholar 

  8. DiGiacomo JE, Hay WW Jr (1989) Regulation of placental glucose transfer and consumption by fetal glucose production. Pediatr Res 25: 429–434

    Article  CAS  PubMed  Google Scholar 

  9. Farber M, Knuppel RA, Binkiewicz A, Kennison RD (1976) Pregnancy and von Gierke's disease. Obstet Gynecol 47: 226–228

    CAS  PubMed  Google Scholar 

  10. Goldzieher JW, Zamah NM (1995) Oral contraceptive side effects: where's the beef? Contraception 52: 327–335

    Article  CAS  PubMed  Google Scholar 

  11. Hannaford PC, Kay CR, Vessey MP, Painter R, Mant J (1997) Combined oral contraceptives and liver disease. Contraception 55: 145–151

    Article  CAS  PubMed  Google Scholar 

  12. Hay WW Jr (1989) Fetal energy and protein metabolism. In: Senterre J (ed) Intrauterine growth retardation, Nestlé Nutrition Workshop Series vol 18. Raven Press, New York, pp 39–64

    Google Scholar 

  13. Hay WW Jr (1992) Placental metabolism and regulation of nutrient transfer to the fetus. In: Lin C-C, Verp MS, Sabbagha RE (eds) The high-risk fetus. Springer, Berlin New York Heidelberg, pp. 66–84

    Google Scholar 

  14. Hay WW Jr (1998) Nutrient and metabolic needs of the fetus and very small infant: a comparative approach. Biochem Soc Trans 26: 75–78

    CAS  PubMed  Google Scholar 

  15. Hay WW Jr (1998) Prologue: placental-fetal metabolic inter-relationships. Biochem Soc Trans 26: 67–69

    CAS  PubMed  Google Scholar 

  16. Hay WW Jr, Sparks JW, Battaglia FC, Meschia G (1984) Maternal-fetal glucose exchange: necessity of a three-pool model. Am J Physiol 246: E528-E5334

    CAS  PubMed  Google Scholar 

  17. Hay WW Jr, Sparks JW, Wilkening RB, Battaglia FC, Meschia G (1984) Fetal glucose uptake and utilization as functions of maternal glucose concentration. Am J Physiol 246: E237-E242

    CAS  PubMed  Google Scholar 

  18. Herrera E (2000) Metabolic adaptations in pregnancy and their implications for the availability of substrates to the fetus. Eur J Clin Nutr 54[Suppl 1]: S47-S51

    Article  CAS  PubMed  Google Scholar 

  19. Johnson MP, Compton A, Drugan A, Evans MI (1990) Metabolic control of von Gierke disease (glycogen storage disease type Ia) in pregnancy: maintenance of euglycemia with cornstarch. Obstet Gynecol 75: 507–510

    CAS  PubMed  Google Scholar 

  20. Kalhan SC (1990) Metabolism of glucose and methods of investigation in the fetus and newborn. In: Polin RA, Fox WW (eds) Fetal and neonatal physiology. Saunders, Philadelphia, pp 357–372

    Google Scholar 

  21. Rice CF, Killick SR, Dieben T, Coelingh Bennink H (1999) A comparison of the inhibition of ovulation achieved by desogestrel 75 micrograms and levonorgestrel 30 micrograms daily. Hum Reprod 14: 982–985

    Article  CAS  PubMed  Google Scholar 

  22. Rijn M, Huitema S, Visser G, Heringa MP, Spronsen FJ, Smit GPA (2000) Dietary management of glycogen storage disease Ia patients in pregnancy. J Inherit Metab Dis 23[Suppl 1]: 162

    Google Scholar 

  23. Rooks JB, Ory HW, Ishak KG, Strauss LT, Greenspan JR, Hill AP, Tyler CW (1979) Epidemiology of hepatocellular adenoma. The role of oral contraceptive use. JAMA 242: 644–648

    Article  CAS  PubMed  Google Scholar 

  24. Ryan IP, Havel RJ, Laros RK Jr (1994) Three consecutive pregnancies in a patient with glycogen storage disease type IA (von Gierke's disease). Am J Obstet Gynecol 170: 1687–1691

    Article  CAS  PubMed  Google Scholar 

  25. Struthers BJ (1991) Copper IUDs, PID, and fertility in nulliparous women. Adv Contracept 7: 211–230

    Article  CAS  PubMed  Google Scholar 

  26. Sugden MC, Holness MJ (1998) Fuel selection: the maternal adaptation to fetal nutrient demand. Biochem Soc Trans 26: 79–86

    CAS  PubMed  Google Scholar 

  27. Weisberg E (1995) Prescribing oral contraceptives. Drugs 49: 224–315

    Article  CAS  PubMed  Google Scholar 

  28. Widdowson EM (1980) The demands of the fetal and maternal tissues for nutrients, and bearing of these on the needs of the mother to “eat for two”. In: Dobbing J (ed) Maternal nutrition in pregnancy—eating for two? Academic Press, London, pp 1–17

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Service de Gynécologie-Obstétrique, Hôpital Antoine-Béclère, 157, rue de la Porte de Trivaux, 92141, Clamart Cedex, France

    Valérie Mairovitz, Hervé Fernandez, Francois Audibert & René Frydman

  2. Service Pédiatrie 1, Hôpital Antoine-Béclère, Clamart, France

    Philippe Labrune

Authors
  1. Valérie Mairovitz
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Philippe Labrune
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hervé Fernandez
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Francois Audibert
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. René Frydman
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hervé Fernandez.

Additional information

Published online: 4 September 2002

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mairovitz, V., Labrune, P., Fernandez, H. et al. Contraception and pregnancy in women affected by glycogen storage diseases. Eur J Pediatr 161, S97–S101 (2002). https://doi.org/10.1007/BF02680004

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02680004

Keywords

Search

Navigation